Malacca Pharmaceutics
Vol. 2 No. 2 (2024): September 2024

Therapeutic Potential of Aceh's Syzygium polyanthum in Reducing Uric Acid in Rattus Norvegicus

Nasrullah, Nasrullah (Unknown)
Siregar, Masra Lena (Unknown)
Suryawati, Suryawati (Unknown)



Article Info

Publish Date
06 Sep 2024

Abstract

This research aims to evaluate the anti-hyperuricemic activity of Syzygium polyanthum ethanolic extract in hyperuricemic male rats (Rattus norvegicus) induced by liver juice.  A total of 25 animals were divided into five groups: a negative control group, a positive control group, and three treatment groups receiving S. polyanthum extract at doses of 150, 200, and 250 mg/kg body weight, respectively. The result showed that the dose of 250 mg/kg body weight resulted in the highest decrease of uric acid plasma, measuring 3.44 ± 2.03 mg/dL. This reduction is comparable to the effect of allopurinol, which showed a decrease of 3.70 ± 1.54 mg/dL. A minimum dose-dependent activity was observed. To conclude, the administration of ethanolic extract of S. polyanthum for 14 days significantly reduced uric acid levels. Further exploration of higher doses or a long-term treatment period to enhance its effectiveness is needed.

Copyrights © 2024






Journal Info

Abbrev

malacca_pharmaceutics

Publisher

Subject

Agriculture, Biological Sciences & Forestry Biochemistry, Genetics & Molecular Biology Chemistry Immunology & microbiology Medicine & Pharmacology

Description

Malacca Pharmaceutics is a premier interdisciplinary platform dedicated to fostering the exchange of cutting edge research and ideas in the rapidly evolving fields of pharmaceutical science and technology. Our mission is to provide a comprehensive and authoritative forum for scientists, researchers, ...